Strong increase of leukocyte apha‐galactosidase A activity in two male patients with Fabry disease following oral chaperone therapy

BACKGROUND: Fabry disease (OMIM 301500) is an X‐linked disorder caused by alpha‐galactosidase A (α‐Gal A) deficiency. The administration of a pharmacologic chaperone (migalastat) in Fabry patients with amenable mutations has been reported to improve or stabilize organ damages and reduce lyso‐Gb3 pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamari, Foudil, Mauhin, Wladimir, Koraichi, Fairouz, Khrouf, Walid, Bordet, Celine, London, Jonathan, Lidove, Olivier, Charron, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732277/
https://www.ncbi.nlm.nih.gov/pubmed/31393666
http://dx.doi.org/10.1002/mgg3.894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732277/
https://www.ncbi.nlm.nih.gov/pubmed/31393666
http://dx.doi.org/10.1002/mgg3.894

Ejemplares similares